Related Experiment Video
Updated: Sep 21, 2026
A Microplate Assay to Assess Chemical Effects on RBL-2H3 Mast Cell Degranulation: Effects of Triclosan without Use of an Organic Solvent
Published on: November 1, 2013
[Problems in chemosensitivity testing]
1Dept. of Surgery, Tokai Central Hospital.
Abstract:
Although chemotherapy is promising as one form of treatment within its field, its therapeutic benefit has yet to be fully utilized because drug sensitivity tests have not been sufficiently used as predictors of response. The currently available prediction accuracy of drug effectiveness is said to be in the range of 60-69%, while the prediction of their ineffectiveness is reportedly 91-97%. The elimination of ineffective drugs is an issue of crucial importance because the side effects of carcinostatic agents are severe. It has been argued that in vivo effects cannot be accurately predicted on the basis of in vitro results for a variety of reasons. There are the roles played by the route of administration, intra-cellular distribution and clearance. In addition, there are also the roles of pharmacokinetics, structural factors related to spheroidal tumors, variations of the micro-cellular environment and so forth in the in vivo situation. To date, a short-time clinical usefulness of sensitivity tests has been reported, but whether there is predictive value for longer-term survival remains to be elucidated.
Insights
Drug sensitivity tests show promise in predicting chemotherapy effectiveness, but their accuracy needs improvement. Identifying ineffective drugs is crucial to avoid severe side effects and improve patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Biomedical Science
Context:
- Chemotherapy offers significant therapeutic potential but faces challenges in predicting patient response.
- Current drug sensitivity tests have limited accuracy in predicting treatment effectiveness (60-69%).
- Predicting drug ineffectiveness is more accurate (91-97%), highlighting the need to avoid ineffective treatments due to severe side effects.
Purpose:
- To evaluate the predictive value of drug sensitivity tests in chemotherapy.
- To address the limitations in accurately predicting patient response to chemotherapy.
- To improve the utilization of chemotherapy's therapeutic benefits by enhancing predictive accuracy.
Summary:
- Drug sensitivity tests are crucial for predicting chemotherapy response, yet their accuracy in predicting effectiveness remains suboptimal.
- Several factors complicate the translation of in vitro sensitivity results to in vivo efficacy, including administration route, pharmacokinetics, and tumor microenvironment.
- While short-term clinical utility of sensitivity tests is documented, their long-term predictive value for patient survival requires further investigation.
Impact:
- Improved patient selection for chemotherapy, minimizing exposure to ineffective and toxic agents.
- Reduction in adverse drug reactions and healthcare costs associated with non-efficacious treatments.
- Advancement in personalized medicine through more reliable prediction of individual patient response to cancer therapies.
